Hematopoietic Stem Cell Transplantation
"Hematopoietic Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.
Descriptor ID |
D018380
|
MeSH Number(s) |
E02.095.147.500.500.500 E04.936.225.687.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematopoietic Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Hematopoietic Stem Cell Transplantation".
This graph shows the total number of publications written about "Hematopoietic Stem Cell Transplantation" by people in this website by year, and whether "Hematopoietic Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 4 | 1 | 5 |
1996 | 6 | 2 | 8 |
1997 | 13 | 0 | 13 |
1998 | 10 | 0 | 10 |
1999 | 12 | 1 | 13 |
2000 | 10 | 2 | 12 |
2001 | 9 | 5 | 14 |
2002 | 7 | 3 | 10 |
2003 | 9 | 5 | 14 |
2004 | 13 | 6 | 19 |
2005 | 10 | 1 | 11 |
2006 | 12 | 5 | 17 |
2007 | 16 | 3 | 19 |
2008 | 15 | 7 | 22 |
2009 | 21 | 9 | 30 |
2010 | 25 | 4 | 29 |
2011 | 17 | 3 | 20 |
2012 | 18 | 5 | 23 |
2013 | 26 | 4 | 30 |
2014 | 22 | 5 | 27 |
2015 | 17 | 4 | 21 |
2016 | 16 | 7 | 23 |
2017 | 19 | 8 | 27 |
2018 | 15 | 7 | 22 |
2019 | 20 | 7 | 27 |
2020 | 34 | 7 | 41 |
2021 | 24 | 7 | 31 |
2022 | 22 | 0 | 22 |
2023 | 27 | 0 | 27 |
2024 | 11 | 9 | 20 |
2025 | 2 | 4 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematopoietic Stem Cell Transplantation" by people in Profiles.
-
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT. Blood. 2025 May 29; 145(22):2561-2573.
-
Peripheral T-cell lymphoma-NOS in children and adolescents: a review from the Children's Oncology Group NHL Committee. Blood Adv. 2025 Mar 25; 9(6):1420-1431.
-
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts. Blood Adv. 2025 Mar 25; 9(6):1442-1451.
-
Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases. Am J Hematol. 2025 Jun; 100(6):1010-1018.
-
SOHO State of the Art Updates and Next Questions | Challenging Scenarios in the Management of Myeloproliferative Neoplasms. Clin Lymphoma Myeloma Leuk. 2025 Jul; 25(7):484-493.
-
US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice Guidelines. Transplant Cell Ther. 2025 May; 31(5):285-296.
-
What have we learned about TP53-mutated acute myeloid leukemia? Blood Cancer J. 2024 Nov 19; 14(1):202.
-
Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemia. Bone Marrow Transplant. 2025 Feb; 60(2):135-143.
-
High-Dose Chemotherapy and Autologous or Allogeneic Transplantation in Aggressive B-Cell Lymphoma-Is There Still a Role? Cells. 2024 10 27; 13(21).
-
Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia. Haematologica. 2025 Apr 01; 110(4):828-839.